earnings
confidence high
sentiment negative
materiality 0.60
Pharma-Bio Serv Q2 revenue down 48% to $2.4M; net loss $0.2M vs income $0.4M
Pharma-Bio Serv, Inc.
2025-Q2 EPS
reported -$0.02
vs consensus $0.03
▼ miss
(-168.6%)
- Q2 revenue $2.4M, decline of $2.2M from $4.6M in prior-year quarter.
- Net loss $0.2M for the quarter; prior-year period net income was $0.4M.
- Six-month revenue $4.8M, down $4.0M; net loss of $0.5M vs income $0.8M.
- Management attributing decline to planned FY2024 investments in new client relationships and global events.